SCHEMBL24624526

SCHEMBL24624526

c1cnc2oc3cnncc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ MAPT P10636 2/20 0.35
▸ NCOA1 Q15788 1/20 0.34
▸ PIK3CA P42336 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ EGFR P00533 2/20 0.32
▸ IGF1R P08069 2/20 0.32
▸ FLT4 P35916 2/20 0.32
▸ KDR P35968 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.31
▸ TGFBR1 P36897 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11884993 0.79 KDM4E (0.50) KDM4EALDH1A1NCOA1NPC1HSP90AA1
SCHEMBL11884996 0.79 KDM4E (0.54) KDM4EALDH1A1MAPTNCOA1PIK3CA
SCHEMBL11884983 0.79 KDM4E (0.55) KDM4EALDH1A1MAPTNCOA1PIK3CA
SCHEMBL29386410 0.78 KDM4E (0.72) KDM4EALDH1A1MAPTNCOA1NPC1
SCHEMBL537382 0.78 KDM4E (0.72) KDM4EALDH1A1MAPTNCOA1NPC1
SCHEMBL25463801 0.77 KDM4E (0.33) KDM4EALDH1A1MAPTPIK3CA
SCHEMBL23177370 0.75 ALDH1A1 (0.46) KDM4EALDH1A1MAPTNPC1HSP90AA1
SCHEMBL25460942 0.75 KDM4E (0.46) KDM4EALDH1A1MAPTNCOA1PIK3CA
SCHEMBL22373883 0.75 KDM4E (0.46) KDM4EALDH1A1MAPTNCOA1PIK3CA
SCHEMBL22373919 0.75 ALDH1A1 (0.46) KDM4EALDH1A1MAPTNCOA1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 KDM4E 3659/4885ALDH1A1 4623/4885MAPT 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback